Industry Information

Update January 04, 2021

In 2020, nine domestic class 1 new drugs (chemical drugs) will be launched, which one is the most popular?

Since 2018, China's a new force suddenly rises. With the support of national policies, the domestic innovative drugs have been effective in the following aspects: efficacy, safety, reliability, and...

Update January 04, 2021

Tianjin medicine, Shanghai medicine to cooperate!

1. Change of ownership On December 20, according to Xinhua news, Tianjin Jinlian Investment Holding Co., Ltd. (hereinafter referred to as "Jinlian holding") and Shanghai Industrial Group Co., Ltd....

Update December 08, 2020

Policy of major medical events in November: focusing on standardization to boost the healthy development of the industry

National Medical Insurance Bureau issued the "operation standard of medical price and bidding and purchasing credit evaluation (2020 Edition)" Recently, the State Medical Insurance Bureau issued the...

Update December 08, 2020

By the end of 2020, the whole process of these drugs should be traceable!

Recently, the drug administration of Shanxi Province issued the work plan for the construction of drug information traceability system. By the end of 2020, the basic development of drug traceability...

Update December 08, 2020

The good prospect of API industry will be an important driving force for the upgrading of pharmaceutical industry

China is one of the largest API producers in the world. After decades of development, China has formed a relatively complete industrial system. In recent years, after adjustment and upgrading, the...

Update December 08, 2020

Investment strategy of API in November: stricter environmental protection policy, overall good, focus on vitamins and antibiotic intermediates

Investment strategy of API in November: stricter environmental protection policy, overall good, focus on vitamins and antibiotic intermediates Core ideas Vitamin industry as a whole In October,...